Yang Zhou1, Melinda L Irwin, Harvey A Risch. 1. Division of Chronic Disease Epidemiology, Yale School of Public Health, P.O. Box 208034, New Haven, CT 06520-8034, USA.
Abstract
OBJECTIVE: The purpose of this study was (1) to investigate the association between BMI self-reported at three time points (during their 20s, 5 years before diagnosis, and post-diagnosis) and mortality among 388 women with newly diagnosed epithelial ovarian cancer and (2) weight change between these 3 time points and mortality. METHODS: Women completed interview-administered questionnaires on average 9 months post-diagnosis. Women were followed 5 years after diagnosis or until death, whichever came first. Cox proportional hazard regression was used to estimate associations between BMI during the 20s, BMI 5 years prior to diagnosis, BMI post-diagnosis (i.e., at the time of interview) and weight changes between these time points and mortality. RESULTS: The 5-year survival rate was 54% (178 deaths, 146 from ovarian cancer). BMI measured continuously at all three time points was associated with a higher risk of ovarian cancer mortality (P≤0.05). The strongest association was observed with BMI in the 20s and all-cause mortality comparing women with BMI≥25 kg/m(2) to BMI<25 kg/m(2) (HR=1.82; 95% CI, 1.02-3.27; P for trend=0.045). For weight change from the 20s to 5 years prior to diagnosis and ovarian cancer specific mortality, we observed a 68% higher risk of ovarian cancer mortality (HR=1.68; 95% CI, 1.11-2.55; P for trend=0.015, comparing women with <10 lbs weight gain to women with ≥10 lbs weight gain). CONCLUSION: BMI prior to and after diagnosis and weight gain throughout adulthood is associated with ovarian cancer mortality.
OBJECTIVE: The purpose of this study was (1) to investigate the association between BMI self-reported at three time points (during their 20s, 5 years before diagnosis, and post-diagnosis) and mortality among 388 women with newly diagnosed epithelial ovarian cancer and (2) weight change between these 3 time points and mortality. METHODS:Women completed interview-administered questionnaires on average 9 months post-diagnosis. Women were followed 5 years after diagnosis or until death, whichever came first. Cox proportional hazard regression was used to estimate associations between BMI during the 20s, BMI 5 years prior to diagnosis, BMI post-diagnosis (i.e., at the time of interview) and weight changes between these time points and mortality. RESULTS: The 5-year survival rate was 54% (178 deaths, 146 from ovarian cancer). BMI measured continuously at all three time points was associated with a higher risk of ovarian cancer mortality (P≤0.05). The strongest association was observed with BMI in the 20s and all-cause mortality comparing women with BMI≥25 kg/m(2) to BMI<25 kg/m(2) (HR=1.82; 95% CI, 1.02-3.27; P for trend=0.045). For weight change from the 20s to 5 years prior to diagnosis and ovarian cancer specific mortality, we observed a 68% higher risk of ovarian cancer mortality (HR=1.68; 95% CI, 1.11-2.55; P for trend=0.015, comparing women with <10 lbs weight gain to women with ≥10 lbs weight gain). CONCLUSION: BMI prior to and after diagnosis and weight gain throughout adulthood is associated with ovarian cancer mortality.
Authors: Kirsten B Moysich; Julie A Baker; Ravi J Menezes; Vijayvel Jayaprakash; Kerry J Rodabaugh; Kunle Odunsi; Gregory P Beehler; Susan E McCann; Jeannine A Villella Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03 Impact factor: 4.254
Authors: Leo J Schouten; Christine Rivera; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Alan Arslan; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Susan E Hankinson; James V Lacey; Michael Leitzmann; Annekatrin Lukanova; James R Marshall; Anthony B Miller; Alpa V Patel; Carmen Rodriguez; Thomas E Rohan; Julie A Ross; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-04-01 Impact factor: 4.254
Authors: Michael F Leitzmann; Corinna Koebnick; Kim N Danforth; Louise A Brinton; Steven C Moore; Albert R Hollenbeck; Arthur Schatzkin; James V Lacey Journal: Cancer Date: 2009-02-15 Impact factor: 6.860
Authors: Luigino Dal Maso; Antonella Zucchetto; Renato Talamini; Diego Serraino; Carmen F Stocco; Marina Vercelli; Fabio Falcini; Silvia Franceschi Journal: Int J Cancer Date: 2008-11-01 Impact factor: 7.396
Authors: Kellie S Matthews; J Michael Straughn; Meredith K Kemper; Kelly E Hoskins; Wenquan Wang; Rodney P Rocconi Journal: Gynecol Oncol Date: 2008-12-05 Impact factor: 5.482
Authors: Rebecca Ann Previs; Joshua Kilgore; Renatta Craven; Gloria Broadwater; Sarah Bean; Sara Wobker; Megan DiFurio; Victoria Bae-Jump; Paola A Gehrig; Angeles Alvarez Secord Journal: Int J Gynecol Cancer Date: 2014-05 Impact factor: 3.437
Authors: Raheem J Paxton; Celia Garcia-Prieto; Maria Berglund; Mike Hernandez; Richard A Hajek; Beverly Handy; Jubilee Brown; Lovell A Jones Journal: Gynecol Oncol Date: 2011-11-23 Impact factor: 5.482
Authors: Sarah A Purcell; Sarah A Elliott; Candyce H Kroenke; Michael B Sawyer; Carla M Prado Journal: Curr Oncol Rep Date: 2016-02 Impact factor: 5.075
Authors: Yang Zhou; Rowan Chlebowski; Michael J LaMonte; Jennifer W Bea; Lihong Qi; Robert Wallace; Sayeh Lavasani; Brian W Walsh; Garnet Anderson; Mara Vitolins; Gloria Sarto; Melinda L Irwin Journal: Gynecol Oncol Date: 2014-04 Impact factor: 5.304